Novartis identifies potent, irreversible myeloperoxidase inhibitors for inflammation Sep. 19, 2017 No Comments
FDA grants priority review to Ryanodex NDA to treat exertional heat stroke March 28, 2017 No Comments
TiGenix initiates phase Ib/IIa trial of Cx-611 to treat sepsis in community-acquired pneumonia Jan. 31, 2017 No Comments